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A combination of genetic and environmental factors can cause autoimmune disease in 
animals. SKG mice, which are genetically prone to develop autoimmune arthritis, fail to 
develop the disease under a microbially clean condition, despite active thymic production 
of arthritogenic autoimmune T cells and their persistence in the periphery. However, in the 
clean environment, a single intraperitoneal injection of zymosan, a crude fungal 
 
 
 
-glucan, 
or purified 
 
 
 
-glucans such as curdlan and laminarin can trigger severe chronic arthritis in 
SKG mice, but only transient arthritis in normal mice. Blockade of Dectin-1, a major 
 
 
 
-glucan 
receptor, can prevent SKG arthritis triggered by 
 
 
 
-glucans, which strongly activate dendritic 
cells in vitro in a Dectin-1–dependent but Toll-like receptor-independent manner. 
Furthermore, antibiotic treatment against fungi can prevent SKG arthritis in an arthritis-
prone microbial environment. Multiple injections of polyinosinic-polycytidylic acid double-
stranded RNA also elicit mild arthritis in SKG mice. Thus, specific microbes, including fungi 
and viruses, may evoke autoimmune arthritis such as rheumatoid arthritis by stimulating 
innate immunity in individuals who harbor potentially arthritogenic autoimmune T cells 
as a result of genetic anomalies or variations.
 
Both genetic and environmental factors con-
tribute to the development of common au-
toimmune diseases, such as rheumatoid arthritis
(RA) and type 1 diabetes (1, 2). However, it
remains obscure how each factor is arranged
into a causal chain of pathogenesis. Given that
T cells are the main mediators of many au-
toimmune diseases, one of the key issues for
elucidating the mechanism of autoimmune
disease would be to understand how genetic
and environmental factors affect the control of
the generation, activation, and expansion of
pathogenic self-reactive T cells.
RA is a chronic systemic inflammatory dis-
ease that primarily affects the synovial mem-
branes of multiple joints (1). Both genetic and
environmental factors are involved in the
pathogenesis (1, 3, 4). For example, MHC and
non-MHC genes play significant roles in de-
termining the genetic susceptibility to RA
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(1, 4, 5). Various infectious agents, including viruses and
bacteria, have also been suspected to be causative agents of
RA, although epidemiological evidence has been elusive
(4, 6, 7). Because T cells, especially CD4
 
 
 
 T cells, play crucial
roles at least in the initial phase of RA, a key question to
understand the etiology of RA would be how genetic and
environmental factors contribute to the generation and activa-
tion of arthritogenic T cells. In this paper, we have addressed
this issue by using a newly established animal model of RA.
SKG mice spontaneously develop T cell–mediated
chronic autoimmune arthritis as a consequence of a mutation
of the gene encoding an SH2 domain of ZAP-70, a key sig-
nal transduction molecule in T cells (8). This mutation im-
pairs positive and negative selection of T cells in the thymus,
leading to thymic production of arthritogenic autoimmune
CD4
 
 
 
 T cells. The mice succumb to symmetrical joint
swelling beginning in small joints of the digits and progress-
ing to larger joints, accompanying severe synovitis with for-
mation of pannus invading and eroding adjacent cartilage
and subchondral bone. They develop rheumatoid factor and
other autoantibodies in the circulation and extra-articular le-
sions, such as interstitial pneumonitis, vasculitides, and subcu-
taneous necrobiotic nodules, not unlike rheumatoid nodules.
Genetic deficiency of IL-6, IL-1, or TNF-
 
 
 
 inhibits the
development of SKG arthritis (9), similar to the effects of
anticytokine therapy in human RA (1). These clinical and
immunopathological characteristics of SKG arthritis make
the strain a suitable model of human RA.
We show in this paper that SKG mice fail to develop ar-
thritis in a microbially clean environment, despite their thy-
mic production of arthritogenic autoimmune T cells that
persist in the periphery. However, under this arthritis-resis-
tant condition, zymosan, a crude yeast cell wall extract, can
provoke severe arthritis in SKG mice, and glucose polymer
 
 
 
-1, 3-D-glucans (
 
 
 
-glucans), which are the main constitu-
ents of zymosan, are responsible for the arthritogenic effect.
Blockade of Dectin-1, a major 
 
 
 
-glucan receptor, is able to
prevent SKG arthritis triggered by 
 
 
 
-glucans. Furthermore,
antibiotic treatment of fungi can prevent SKG arthritis in an
arthritis-prone microbial environment. Polyinosinic-poly-
cytidylic acid (poly[I:C]), a double-stranded RNA, also
showed a mild arthritogenic effect in SKG mice. Thus, cer-
tain microbes, such as fungi and viruses, may activate arthri-
togenic T cells through stimulating innate immunity, thereby
evoking chronic autoimmune arthritis in the individuals
who are genetically prone to produce arthritogenic autoim-
mune T cells that persist in the periphery.
The present results illustrate how a specific combination
of genetic and environmental factors in the generation and
activation of autoimmune T cells leads to the development
of a particular autoimmune disease, and will help design the
measures to prevent autoimmune disease in genetically sus-
ceptible individuals by controlling autoimmune-eliciting en-
vironmental agents, or blocking their effects on the immune
system at the molecular level.
 
RESULTS
Environmental stimuli trigger chronic arthritis in SKG mice
 
SKG mice failed to develop chronic arthritis in our strictly
controlled specific pathogen-free (SPF) environment, although
all SKG mice developed the disease by 6 mo under our con-
ventional microbial condition (non-SPF; Fig. 1 A and refer-
ence 8). To examine whether vertical or horizontal environ-
mental agents are responsible for eliciting arthritis in SKG mice
under the non-SPF condition, 7-d-old SKG mice born in the
SPF environment were foster nursed to BALB/c mice in the
non-SPF environment or 8-wk-old nonarthritic SPF SKG
mice were transferred to the non-SPF facility. Both groups de-
veloped arthritis as severe as non-SPF SKG mice (Fig. 1 A).
However, in the strict SPF condition, transfer of spleno-
cytes or thymocytes from SPF-born nonarthritic SKG mice
to BALB/c athymic nude mice produced severe arthritis
(Fig. 1 B). Transfer of T cell–depleted BM cells from nonar-
thritic SPF SKG mice also produced severe arthritis in SCID
mice, indicating that SKG BM cells differentiated through
the SCID thymus to arthritogenic T cells and became acti-
vated in the periphery without exposure to a putative arthri-
togenic environmental agent (Fig. 1 B).
Together, SKG mice fail to develop arthritis in our mi-
crobially clean environment despite continuous thymic pro-
duction of arthritogenic T cells and their persistence in the
periphery. Certain environmental agents that act on SKG
mice horizontally can trigger arthritis. Furthermore, antigen-
nonspecific proliferative stimulation, as in the case of pre-
sumable homeostatic T cell proliferation upon transfer to the
T cell–deficient environment of nude mice, suffices to acti-
vate dormant arthritogenic T cells to cause arthritis.
 
Triggering of arthritis in SPF SKG mice by chemical or 
biological compounds
 
Next, we attempted to determine whether any chemical or
biological compounds known to affect T cells, B cells, or
APCs can trigger arthritis in SPF SKG mice (Fig. 1 C). A
single i.p. injection of zymosan elicited the most severe ar-
thritis at the highest incidence. Injection of poly(I:C), three
times per week for 17 wk, also triggered mild arthritis in the
majority of treated mice (10, 11). Cyclophosphamide (CP)
at 1 mg/mouse, the dose causing temporary lymphopenia
and used to elicit diabetes in NOD mice (12), produced
mild arthritis at a significantly high incidence compared with
PBS-treated controls. Administration of CpG or agonistic
anti-CD40 mAb, at the doses eliciting autoimmunity in
other systems, failed to trigger arthritis (13–15). A single in-
jection of ConA, pristane, and LPS and two i.v. injections of
pertussis toxin (PTX), at a dose reported to have biological
effects, elicited mild arthritis at a low incidence (14, 16–18).
SKG mice were sensitive to high doses of LPS (e.g., 1 mg);
many of the treated mice died immediately after treatment
and those that survived did not develop arthritis (unpub-
lished data). Thus, zymosan, poly(I:C), and CP can effec-
tively provoke arthritis in SPF SKG mice. 
JEM VOL. 201, March 21, 2005
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Possible roles of fungi in triggering arthritis in SKG mice
 
The strong arthritogenic effect of zymosan in SKG mice
prompted us to examine possible fungal infection in non-SPF
SKG mice. Specific detection of fungal 18S-ribosomal RNA
gene (18SrDNA) revealed fungal infection in the lungs and
some esophagi, but not in the livers or ankles, of 12-wk-old
non-SPF SKG mice (Fig. 2 A and reference 19). Real-time
quantitative PCR analysis revealed that the lungs from
non-SPF mice had a significantly higher concentration of
fungi than those in the SPF condition (Fig. 2 B). Non-SPF
SKG mice harbored larger amounts of fungi than BALB/c
(Fig. 2 B), indicating that SKG mice are more susceptible to
infection than BALB/c mice, presumably due to the dysfunc-
tion of SKG T cells bearing the ZAP-70
 
skg
 
 mutation (8).
DNA sequencing of PCR products for 18SrDNA or internal
transcriber spacer 1 (ITS1) identified five species of fungi
in the lungs of non-SPF SKG mice (19, 20): 
 
Pneumocystis
murina
 
, 
 
Cladosporium cladosporioides
 
, 
 
Graphium rubrum, Alternaria
alternata,
 
 and 
 
Aspergillus nidulans
 
 (see Table S1, available at
http://www.jem.org/cgi/content/full/jem.20041758/DC1).
Figure 1. Chemical or biological compounds trigger arthritis in 
SKG mice. (A) Arthritis scores of 6-mo-old SKG mice maintained in the 
indicated environment. SPF-born nonarthritic SKG mice were foster 
nursed to non-SPF BALB/c mice at 7 d of age or transferred to the non-SPF 
environment at 8 wk of age. (B) 5   107 splenocytes, 108 thymocytes, or 
5   106 BM cells prepared from each nonarthritic SPF SKG mouse were 
adoptively transferred to individual 6-wk-old nude or SCID mice. BM cells 
were T cell depleted by treatment with anti–Thy-1, anti-CD4, and anti-CD8 
antibodies and rabbit complement before transfer. Arthritis scores 6 mo 
after transfer are shown. (C) Arthritis scores of SPF SKG mice 5 mo after 
administration of indicated compounds. SKG mice between 8 and 12 wk 
of age maintained in the SPF environment were treated as follows: 
i.p. injection of 2 mg zymosan, 1  g LPS, 200  g ConA, 500  l pristane, 
1 mg CP, or 150  l PBS; i.v. administered with 400 ng PTX on days 0 and 2; 
i.p. 150  g poly(I:C) or 150  l PBS three times per week for 17 wk, 10 nmol 
CpG or non-CpG once per week for 4 wk; and i.v. with 0.3 mg agonistic 
anti-CD40 or control rat IgG on days 0, 7, and 14. 
 
 
-GLUCANS TRIGGER AUTOIMMUNE ARTHRITIS IN SKG MICE | Yoshitomi et al.
 
952
 
Methenamine silver staining of the lungs indeed revealed ar-
gyrophilic cysts in non-SPF SKG mice, corresponding to
be 
 
P. murina
 
 infection (Fig. 2, C and D), but not in non-
SPF BALB/c mice (Fig. 2, E and F). Inflammation was
minimal surrounding the fungi, and filamentous fungi were
histologically undetectable in non-SPF SKG lungs (Fig. 2,
C and D).
To determine the possible contribution of fungi to trig-
gering arthritis in SKG mice, non-SPF SKG mice were
treated with amphotericin B, which has a broad antifungal
property and reportedly reduces the viability of 
 
Pneumocys-
tis carinii
 
 (21). The treatment prevented SKG arthritis in
the non-SPF condition (Fig. 2 G), whereas it did not alter
the course of zymosan-triggered SKG arthritis in the SPF
condition (Fig. 2 H), indicating that the arthritis-preven-
tive effect of amphotericin B is due to its antifungal activ-
ity, not to its possible immunosuppressive side effects. Fur-
thermore, 
 
 
 
-glucan, a major component of fungi, was
detected in the sera of SKG mice under the non-SPF con-
dition (3,175 
 
 
 
 4,021 pg/ml), compared with under the
SPF condition (63 
 
 
 
 72 pg/ml; Fig. 2 I). These results col-
lectively indicate that fungi can be a key agent to trigger
arthritis in SKG mice, at least in our conventional non-
SPF condition.
Figure 2. Silent fungal infections under non-SPF trigger arthritis 
in SKG mice. (A) PCRs of fungal 18SrDNA or mouse Rag 1 gene from 
esophagus (Es), lung (Lg), liver (Lv), or foot including ankle joint (Ft) of 
BALB/c or SKG mice in non-SPF. (B) Lungs of BALB/c or SKG mice in 
non-SPF or SPF were assessed for fungi by real-time quantitative PCR. 
(C–F) Methenamine silver (C and E) or hematoxylin and eosin (D and F) 
stainings of lungs from SKG mice (C and D) or BALB/c (E and F) of non-SPF. 
Arrows indicate argyrophilic fungal cysts. (G) Male SKG mice of 10 wk of 
age in the non-SPF facility were treated with four cycles of four daily i.p. 
injections of 75  g amphotericin B (arrows) at 10-d intervals. (H) SKG 
mice in the SPF facility received the same protocol of antifungal treatment 
10 d after i.p. administration of 2 mg zymosan (open inverted triangle). 
(I) Concentration of serum  -glucan in non-SPF or SPF 12-wk-old SKG mice. 
JEM VOL. 201, March 21, 2005
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Purified 
 
 
 
-glucans are strong inducers of arthritis in SKG mice
 
Among the constituents of zymosan, such as 
 
 
 
-glucans,
mannan, chitin, and proteins, 
 
 
 
-glucan is known to be asso-
ciated with fungal pathogenicity (22). To assess whether
 
 
 
-glucan is responsible for triggering arthritis in SKG mice,
we administered the purified 
 
 
 
-glucans, curdlan, or lami-
narin to SKG or BALB/c mice (Fig. 3). Curdlan is a linear
 
 
 
-1,3-glucan of 
 
 
 
500-mers derived from the bacterium
Figure 3. Purified  -glucans trigger arthritis in SKG mice. (A and B) 
Arthritis score and incidence of SKG mice or BALB/c in the SPF environment 
after a single i.p. injection of indicated amounts of (A) curdlan or (B) laminarin. 
Vertical bars represent the means   SD. Arthritis scores are significantly dif-
ferent (P   0.05) between SKG and BALB/c mice treated with 3 mg curdlan dur-
ing 2–17 wk; between SKG mice treated with 3 and 10 mg curdlan during 4–7 
wk; between SKG and BALB/c mice treated with 30 mg laminarin during 3–17 
wk; and between SKG mice treated with 3 and 30 mg laminarin during
4–17 wk. (C–H) Hematoxylin and eosin staining of ankle joints. Arthritic joints 
of SPF SKG mice 20 wk after treatment with 2 mg zymosan (C), 30 mg lami-
narin (D), or 3 mg curdlan (E). (F and G) An arthritic (F, 8 wk after treatment) or 
cured (G, 20 wk) ankle joint from BALB/c mice with transient arthritis triggered 
by 3 mg curdlan. (H) An ankle joint of 40-wk-old nonarthritic SKG mice in SPF. 
(I) Arthritis scores of BALB/c or SKG donor mice 9 wk after administration 
of 2 mg zymosan. Nude mice were transferred with 5   107 splenocytes from 
arthritic BALB/c or SKG mice and assessed for arthritis 12 wk after transfer. 
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Figure 4. Purified  -glucans activate BM-DCs. (A) The expression of 
CD86 on CD11c  BM-DCs cultured with laminarin, curdlan, or zymosan at 
indicated concentrations. (B) The expression of indicated surface markers 
on CD11c  BM-DCs cultured with 1  g/ml LPS, 10 mg/ml laminarin, 100 
 g/ml curdlan, or 100  g/ml zymosan. Percentages of positive cells are 
also shown. (C) The expression of CD86 on TLR4-, TLR2-, or MyD88-deficient 
or wild-type CD11c  BM-DCs cultured with 10 mg/ml laminarin (LAM), 
100  g/ml curdlan (CDL), 10  g/ml LPS, or 10  g/ml Pam3CSK4. (D) BM-DCs 
were incubated with or without 100  g/ml of laminarin for 1 h before the 
culturing with 10  g/ml of curdlan or zymosan (ZYM), and assessed for 
CD86 expression. (E) The expression of Dectin-1 on unstimulated DCs or 
DCs activated by 1  g/ml LPS, 10 mg/ml laminarin, 100  g/ml curdlan, or 
100  g/ml zymosan. (F) BM-DCs were incubated with 10  g/ml of 2A11 
anti–Dectin-1 mAb or isotype-control IgG for 1 h before culture with indi-
cated  -glucans or cultured with  -glucans alone. The expression of CD86 
on CD11c  BM-DCs 24 h after the stimulation is shown. Shaded histograms 
indicate unstimulated DCs in A, C, D, and F or staining controls in B and E. 
Ordinate indicates cell number. A representative result of three independent 
experiments is shown in A–F. 
JEM VOL. 201, March 21, 2005
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Alcaligenes faecalis
 
; laminarin consists of short, soluble 
 
 
 
-1,3-
and some 
 
 
 
-1,6-glucans (
 
 
 
10,000 MW) derived from sea-
weed 
 
Laminaria digitata
 
. Administration of 3 mg curdlan or
30 mg laminarin triggered severe chronic arthritis in all the
treated SKG mice and produced transient arthritis in 50 and
 
 
 
10%, respectively, of BALB/c mice (Fig. 3, A and B).
SKG mice treated with 2 mg zymosan showed a similar se-
verity and time course of disease progression (Fig. 2 H and
Fig. 6 A). Histology of swollen joints in curdlan- or lami-
narin-treated mice, whether SKG or BALB/c, exhibited se-
vere synovitis accompanying massive subsynovial infiltration
of neutrophils, lymphocytes, macrophages, and plasma cells
and villous proliferation of synoviocytes. However, synovitis
in BALB/c mice was transient and reverted to normal histol-
ogy in 4 mo (Fig. 3, C–H).
To determine whether 
 
 
 
-glucan–induced arthritis in
SKG or BALB/c mice was a T cell–mediated autoimmune
disease, we transferred splenocytes from arthritic SKG or
BALB/c mice to BALB/c nude mice (Fig. 3 I). Transfer of
splenocytes from arthritic SKG produced arthritis in all the
recipients in 3 mo, whereas transfer from BALB/c mice did
not. Thus, 
 
 
 
-glucans can evoke T cell–mediated autoim-
mune arthritis in SKG mice, but only transient synovial in-
flammation in BALB/c mice; the latter is apparently not me-
diated by autoimmune T cells.
 
 
 
-Glucans activate BM-DCs in a Dectin-1–dependent manner
 
Although zymosan is known to activate BM-DCs through
Toll-like receptor (TLR)2 and 6 as well as  -glucan recep-
tors, it is not clear yet whether purified  -glucans have a sim-
ilar effect (23, 24). Adding curdlan or laminarin to the cul-
ture of immature DCs that were induced in vitro from BM
cells revealed that these  -glucans were able to activate im-
mature DCs as indicated by up-regulation of CD86 in a
dose-dependent fashion (Fig. 4 A). Laminarin, curdlan, and
zymosan also up-regulated the expression of CD40, CD80,
and class II MHC (I-Ad) on DCs (Fig. 4 B). To assess the
possibility that DC activation was induced by contaminated
LPS or by direct interaction between  -glucan and TLRs,
we cultured immature BM-DCs prepared from TLR4-,
MyD88-, or TLR2-deficient mice with purified  -glucans
and assessed CD86 expression (Fig. 4 C). Laminarin or curd-
lan equally enhanced the expression of CD86 on DCs pre-
pared from either these knockout or wild type mice, whereas
LPS and Pam3CSK4, a synthetic ligand of TLR2, was inef-
fective on TLR4-deficient DCs and TLR2- or MyD88-defi-
cient DCs, respectively (25–27). This indicates that DC acti-
vation by  -glucans is not due to direct stimulation of TLR2
or MyD88-dependent pathway or to stimulation of TLR4
by possible LPS contaminant in the  -glucan preparation.
Laminarin is known to competitively inhibit the binding
of other  -glucans to their receptors (28–31). Indeed, a non-
stimulatory dose (100  g/ml) of laminarin blocked the acti-
vation of BM-DCs by stimulatory doses (10  g/ml) of curd-
lan (Fig. 4 D), indicating that these two  -glucans share the
same receptor other than the TLR. In contrast, this dose of
laminarin failed to block the activation of BM-DCs by 10
 g/ml zymosan, which can also interact with TLR2 and
TLR6 (Fig. 4 D and reference 24).
Among  -glucan receptors, Dectin-1 is known to play a
major role in mediating many biological responses to  -glu-
cans (32, 33). Staining with 2A11 anti–Dectin-1 mAb re-
vealed that Dectin-1 was highly expressed on DCs, espe-
cially on immature DCs, and activation slightly decreased
the expression (Fig. 4 E). When 2A11 was added before cul-
turing DCs with curdlan or zymosan, DC activation with
curdlan was blocked in a dose-dependent manner, but the ac-
tivation by zymosan was not (Fig. 4 F and Fig. S1, available at
http://www.jem.org/cgi/content/full/jem.20041758/DC1).
Although Dectin-1 stimulation is known to enhance
TLR-stimulated cytokine formation, it is unclear whether
Dectin-1 stimulation alone can provoke cytokine formation
(32, 33). In Fig. 5 A, purified  -glucans induced TNF- 
production by DCs as shown previously with a macrophage
cell line (34). 2A11 completely blocked this curdlan-stimu-
lated TNF-  production, whereas it did not affect zymosan-
stimulated production (Fig. 5 B). Furthermore, MyD88
deficiency only slightly reduced curdlan-stimulated TNF- 
production, in contrast with significant reduction in zymo-
san-stimulated production (Fig. 5 C). These results collec-
tively indicate that Dectin-1 stimulation alone, without TLR
engagement, can induce TNF-  production, although zy-
mosan appears to induce the production through both Dec-
tin-1 and TLR (32, 33).
In contrast with TNF-  production, the amount of IL-12
produced by laminarin- or curdlan-stimulated DCs was low
(30 pg/ml) or undetectable, respectively, compared with
 200 pg/ml of IL-12 produced by zymosan-stimulated
DCs (Fig. S2, available at http://www.jem.org/cgi/con-
tent/full/jem.20041758/DC1). This indicates that stimula-
tion of DCs through TLRs, rather than Dectin-1, is crucial
for IL-12 production (32).
Together, purified  -glucans can induce maturation
of DCs (Fig. 4) and production of cytokines (Fig. 5)
mainly through Dectin-1, but not through TLRs or other
 -glucan receptors such as CR3, scavenger receptors, or
lactosylceramide.
Blockade of Dectin-1 inhibits  -glucan–induced arthritis in 
SKG mice
To determine whether the in vivo arthritogenic effect of
curdlan, laminarin, and zymosan is via Dectin-1, we treated
SKG mice with 2A11 before and after injection of these
compounds. The treatment significantly delayed the onset
of arthritis in SKG mice treated with either compound, and
significantly reduced both the incidence and severity of ar-
thritis in laminarin-treated SKG mice (Fig. 6 A). The ad-
ministered antibody bound to Dectin-1–expressing cells
but did not deplete them, indicating that the mAb blocked
Dectin-1 in vivo (Fig. 6 B). Analysis of collagen-digested -GLUCANS TRIGGER AUTOIMMUNE ARTHRITIS IN SKG MICE | Yoshitomi et al. 956
synovial cell suspensions from laminarin-treated arthritic
SKG mice revealed several types of cells in the inflamed
synovium (Fig. 6 C); i.e.,  10% of cells were Gr-1low
CD11b  monocytes/macrophages, which were Dectin-1high;
 20% were Gr-1  CD11b  granulocytes. More than half
of Dectin-1–expressing CD11b  cells were class II MHC ,
indicating that the arthritic synovium of SKG mice contains
numerous Dectin-1  macrophages. These results, together
with the development of transient arthritis in normal
BALB/c mice by i.p. injection of  -glucan (Fig. 3, A and
B), indicate that circulating  -glucans can activate Dectin-
1–expressing synovial cells, including synovial macrophages/
DCs and granulocytes, and that blockade of Dectin-1 on
the synovial cells can inhibit the activation of synovial cells
to mediate synovitis and also to activate arthritogenic T
cells.
DISCUSSION
The main findings in this paper are that microbial com-
pounds, especially  -glucans, can evoke T cell–mediated au-
toimmune arthritis in SKG mice, which are genetically
prone to produce arthritogenic self-reactive T cells, but fail
to develop the disease in a clean environment. This indicates
that a specific combination of a genetic T cell abnormality
and exposure to particular microbes capable of strongly acti-
vating innate immunity is able to produce overt T cell–
mediated autoimmune disease, but either alone is not.
SKG mice spontaneously suffer from severe arthritis in a
conventional environment, but not under SPF conditions.
Transfer of nonarthritic SPF SKG mice to a non-SPF envi-
ronment after weaning elicited arthritis. However, under a
strict SPF condition, simply transferring peripheral T cells or
thymocytes from nonarthritic SKG mice to syngeneic nude
mice effectively produced arthritis. When taken together,
these results indicate the following: (a) the thymi of SKG
mice are continuously producing arthritogenic T cells,
which persist in the periphery but are unable to mediate
arthritis unless exogenously stimulated; (b) environmental
agents, including microbes, that horizontally affect the im-
mune system may trigger T cell–mediated chronic arthritis
in SKG mice; and, importantly, (c) antigen-nonspecific gen-
eral activation of T cells, like homeostatic proliferation as
seen upon transfer of T cells to T cell–deficient nude mice,
may suffice to activate dormant arthritogenic T cells to
mediate arthritis.
Among various chemical or biological compounds tested
in the present work, the most potently arthritogenic in SKG
mice were  -glucans. Dectin-1, a receptor mediating main
biological response to  -glucans in vitro and in vivo, is ex-
pressed on cells of the monocyte/macrophage and neutrophil
lineages, and at lower levels on splenic DCs and a subpopula-
tion of splenic T cells (35). It has been shown that  -glucans,
zymosan in particular, induce the production of reactive ox-
ygen, nitrogen intermediates, and proinflammatory cyto-
kines by macrophages and neutrophils and enhance phago-
cytosis by macrophages (22, 36). We have shown in this paper
that purified  -glucans can stimulate BM-DCs to maturate
and form cytokines including TNF- , and that this DC acti-
vation was dependent on Dectin-1 but not TLRs. Further-
more, blockade of Dectin-1 significantly reduced the in-
cidence and severity of arthritis. Although expression of
Dectin-1 on T cells suggests the possibility that  -glucans
may also directly stimulate arthritogenic T cells, this is un-
likely as the major mechanism of  -glucan–induced SKG ar-
thritis because the expression of Dectin-1 on splenic T cells
was confined to a minor subset of CD8  GR-1  T cells in
SKG and BALB/c mice (35) and because  -glucans exhib-
ited no direct cell-proliferative or cytokine-inducing effects
on T cells in vitro (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20041758/DC1). Together, it is likely
in SKG mice that administered  -glucans, or their degraded
products with lower molecular weights, activate Dectin-1–
Figure 5. Production of TNF-  by  -glucan–stimulated DCs. (A) 
BM-DCs were incubated with 10 mg/ml laminarin, 100  g/ml curdlan, 100 
 g/ml zymosan, or 1  g/ml LPS from day 5 for 24 h and the amount of 
TNF-  was assessed by ELISA. (B) TNF-  production by BM-DCs that were 
incubated with 10  g/ml of 2A11 mAb or control IgG2b for 1 h before cul-
ture with 100  g/ml curdlan or 100  g/ml zymosan. (C) TNF-  production 
by MyD88-deficient or wild-type BM-DCs that were cultured with 100  g/ml 
curdlan, 100  g/ml zymosan, or 10  g/ml LPS. Vertical bars represent the 
means   SD of triplicates.JEM VOL. 201, March 21, 2005 957
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expressing APCs, including DCs/macrophages in the syn-
ovium, enhancing their presentation of joint self-antigens to
arthritogenic T cells. The strong arthritogenic activity of
 -glucans could also be attributed in part to their persistence
in the circulation. Fungal  -glucans produced at the infec-
tion sites, such as lung, may circulate to the joints and elicit
arthritis by activating synovial cells (37, 38). However, it is
of note that in contrast with effective triggering of arthritis
by parenteral exposure to  -glucans, oral administration of a
large amount of zymosan for 3 wk failed to elicit arthritis in
SKG mice, indicating that orally taken  -glucans may be lit-
tle absorbed in the digestive system (unpublished data).
Administration of  -glucans elicited not only chronic ar-
thritis in SKG mice but also transient and reversible arthritis
in BALB/c mice. The latter can also be produced in normal
animals by direct injection of zymosan into the joint (39).
However, the  -glucan–induced arthritis in BALB/c mice
was not transferable to nude mice by splenic T cells. These
findings collectively indicate that  -glucans can directly acti-
vate synovial macrophages/DCs and cause synovial inflam-
mation presumably because synovial cells are sensitive to
various chemical or biological stimuli and intrinsically capa-
ble of producing proinflammatory cytokines upon stimula-
tion (8, 9, 40, 41). However, this synovial inflammation is
not sufficient to evoke chronic T cell–mediated autoim-
mune arthritis unless the mice harbor arthritogenic T cells
sufficient in number or TCR specificity, or both, to mediate
chronic synovitis. Supporting this role of environmental
compounds to trigger T cell–mediated autoimmune disease,
several papers have shown that inoculation of CpG, heat-
shock proteins, or agonistic anti-CD40 monoclonal antibody
initiated overt autoimmune disease such as diabetes and en-
cephalomyelitis in mice expressing transgenic TCRs specific
for self- or surrogate self-antigens expressed in the target or-
gans/tissues (14, 15, 42). On the other hand, there are re-
ports that administration of activated DCs pulsed with organ
specific self-peptides can only produce transient or local au-
toimmunity in normal animals; for example, local admin-
istration of activated DCs loaded with type II collagen
peptides elicited only localized arthritis at the site of injec-
tion (43, 44). Thus, our results together with these findings
indicate that activation of APCs by environmental agents
may provoke transient and self-limiting or chronic and pro-
gressive autoimmune disease depending on the quality and
quantity of autoimmune T cells present in the host at the
time of exposure to the agents. Among various types of
human arthritides of unknown etiology, some, especially
chronic ones like RA, may be caused by a combination of
exposure to APC-activating environmental agents and the
production/persistence of arthritogenic T cells; others, espe-
cially infectious ones, may be due to direct effects of envi-
ronmental agents on the synovium, which is highly sensitive
to various stimuli and, upon activation, capable of secreting
proinflammatory cytokines and chemical mediators (1). Our
results also imply that one-time “hit-and-run” exposure to
an arthritogenic environmental compound may suffice to
trigger chronic arthritis if arthritogenic autoimmune T cells
are already present in the immune system.
Figure 6. Dectin-1 as a major receptor for  -glucans in triggering 
SKG arthritis by  -glucans. (A) 0.5 mg 2A11 anti–Dectin-1 mAb or rat 
IgG were administered i.v. into SPF SKG mice two or three times, 2 wk 
apart (closed triangle), before or after i.p. injection of indicated amounts of 
laminarin, curdlan, or zymosan (open triangle). Vertical bars represent the 
means   SD. Asterisks indicate significant differences (P   0.05) at the 
indicated time points. (B) SKG mice were treated i.v. with 0.5 mg 2A11 or 
rat IgG, and the expression of CD11b and surface-bound rat IgG or Dectin-1 
on peripheral blood was analyzed 1 wk later. (C) The synovium from arthritic 
SKG mice treated with 30 mg laminarin was digested for 1 h; resulting 
single cell suspensions were analyzed for the expression of indicated sur-
face markers. Shaded histograms indicate staining controls. A representative 
result of three independent experiments is shown in B and C. -GLUCANS TRIGGER AUTOIMMUNE ARTHRITIS IN SKG MICE | Yoshitomi et al. 958
In addition to  -glucans, other chemical or biological
compounds could trigger arthritis in SKG mice at various
degrees. For example, repeated administration of poly(I:C)
produced mild arthritis in all the treated mice, presumably
by stimulating the production of type I interferons and acti-
vating synovial macrophages/DCs via TLR3 (45). Although
a single dose of LPS evoked arthritis in some SKG mice, it
remains to be determined whether multiple injections can
trigger the disease at a higher incidence. Mild arthritis was
also induced by PTX, which causes nonspecific proliferation
of T cells via activation of APCs with its catalytic ADP-
ribosyltransferase activity (46), or by cyclophosphamide,
which produces transient lymphocytopenia and reduction of
CD25 CD4  natural regulatory T cells (12, 47, 48). The
ZAP-70skg mutation itself affects the function of natural
CD25 CD4  regulatory T cells in the control of arthritoge-
nic T cells (unpublished data). Thus, not only fungi but also
viruses or bacteria may be potentially able to trigger arthritis
in SKG mice by activating innate immunity, or by periph-
eral control of arthritogenic T cells. Furthermore, it is likely
that SKG mice are more susceptible to such arthritogenic
microbial infections than normal mice because the ZAP-
70skg mutation not only alters thymic T cell selection and the
resulting T cell repertoire, but also reduces the responsive-
ness of peripheral T cells to microbes (8). It remains to be in-
vestigated whether other biological, chemical, or physical
insults that activate innate immunity or alter peripheral con-
trol of T cell activation/expansion can also trigger arthritis in
SKG mice.
In conclusion, environmental agents, such as fungi and
viruses, may evoke autoimmune arthritis similar to RA in
genetically susceptible individuals who already harbor arthri-
togenic T cells through stimulating APCs in an antigen non-
specific manner and thereby activating preexisting arthritogenic
T cells. Similar combinations of genetic and environmental
factors may cause other autoimmune diseases as well.
MATERIALS AND METHODS
Mice.  SKG or BALB/c mice (Clea Japan) were maintained in our animal
facility under non-SPF conditions or strictly controlled SPF facility. TLR2,
TLR4, or MyD88-deficient mice were backcrossed to C57BL6 more than
eight times and maintained in SPF conditions (25, 27). All experiments
were conducted according to the institutional guidelines for animal welfare.
Clinical assessment of SKG arthritis. Joint swelling was monitored by
inspection and scored as follows: 0, no joint swelling; 0.1, swelling of one
finger joint; 0.5, mild swelling of wrist or ankle; and 1.0, severe swelling of
wrist or ankle. Scores for all fingers and toes, wrists, and ankles were totaled
for each mouse. Female mice were used unless otherwise stated.
Reagents. Cyclophosphamide, ConA, pristane, poly(I:C), PTX, LPS, zy-
mosan A, laminarin, and rat IgG were purchased from Sigma-Aldrich; curd-
lan was obtained from Wako; anti-CD4 (H129.19), anti-CD8a (53–6.7),
anti-CD11b (M1/70), anti-CD40 (3/23), anti-CD11c (HL3), anti-CD80
(16-10A1), anti-CD86 (GL-1), and anti-IAd (AMS-32.1) were obtained
from BD Biosciences; isotype-control rat IgG2b (KLH/Gb-1-2) was ob-
tained from eBioscience; and FITC-F(ab )2 mouse anti–rat IgG was ob-
tained from Jackson ImmunoResearch Laboratories. Oligodeoxynucleotide
(ODN) 1668 CpG, 5 -TCCATGACGTTCCTGATGCT-3 , and ODN-
AP1 non-CpG, 5-GCTTGATGACTCAGCCGGAA-3  were synthesized
by Hokkaido System Science (13). Anti–Dectin-1 (2A11) (31) or agonistic
anti-CD40 (FGK 45) (49) have been reported previously. Curdlan or lami-
narin were suspended or dissolved in PBS at 30 or 100 mg/ml, respectively,
before i.p. injection. Curdlan for culture was dissolved in 0.15 N NaOH at
10 mg/ml as described previously (34).
PCR. Tissues were lysed in 50 mM Tris-HCl, pH 7.5, 20 mM EDTA, 1%
SDS, 100 mM NaCl, and 400  g/ml proteinase K (Nacalai Tesque) and
DNA was extracted by phenol-chloroform. For fungal 18S rDNA and
ITS1, the reaction mixture (25  l) contained 0.2 mM dNTP, 0.8  M for-
ward and reverse primer, and 1.0 U Ex-Taq DNA polymerase (Takara) in
supplier’s buffer. PCRs were performed on a PTC-200 Programmable
Thermal Control (MJ Research Inc.). PCRs consisted of a 5-min at 94 C
denaturation step followed by 40 cycles of 30 s at 94 C, 30 s at 60 C, and
30 s at 72 C. For the murine Rag1 gene, PCRs were performed as de-
scribed before except that denaturing temperature was 95 C for 9 min, an-
nealing temperature was 56 C, and the number of cycles was 35 with Taq
Gold (Applied Biosystems). The primer sequences were as follows: fungal
18S rDNA (19), B2F, 5 -ACTTTCGATGGTAGGATAG-3  and B4R,
5 -TGATCGTCTTCGATCCCCTA-3 ; fungal ITS1 (20), 18SF1, 5 -
AGGTTTCCGTAGGTGAACCT-3  and 58SR1, 5 -TTCGCTGCGT-
TCTTCATCGA-3 ; and murine Rag1, Rag1F 5 -CTTCGGAATGC-
CGAGAAAGT-3  and Rag1R, 5 -TGTGAAGGGACCATTCAGGT-3 .
18S rDNA or Rag1 were quantified by real-time PCR using the ABI/
PRISM 7700 sequence detection system (Applied Biosystems). For
18SrDNA PCRs contained 0.3  M primers, SYBR green PCR Kit
(QIAGEN) and MgCl2 to 3.5 mM, and consisted of a 15-min at 95 C de-
naturation step followed by 47 cycles of 15 s at 94 C, a 30-s annealing step
at 53 C, a 30-s extension step at 72 C, and a 15-s detection step at 76 C.
For Rag1 detection, the annealing step was 54 C and the detection was
merged with extension at 72 C for 30 s with default MgCl2 concentration.
PCR products of 18S rDNA or ITS1 were electrophoresed in agarose
1.5% gel, visualized by staining with ethidium bromide, cut out, and puri-
fied with a gel extraction kit (QIAGEN). Initial PCR products were di-
rectly sequenced with ABI PRISM 3100 Genetic Analyzer (Applied Biosys-
tems) according to manufacturer’s manual. When the result shows a mixture
of different sequences, the PCR product was subcloned with pGEMeasy
(Promega) and sequenced. Obtained sequence was analyzed with BLAST in
the National Center for Biotechnology Information.
Measurement of serum  -glucan.  Mixture of serum and double vol-
ume of 0.32 M perchloric acid was incubated at 37 C for 20 min and cen-
trifuged at 1,000 g for 15 min; supernatant was mixed with the same volume
of 0.18 N NaOH and further diluted with 0.01 N NaOH (50). The con-
centration of  -glucan was measured by BGSTAR KIT (Wako), a limulus
test specific for  -glucan, according to manufacturer’s instruction (37).
Histology. Lungs or ankle joints were fixed in buffered 10% formalin, and
paraffin-embedded sections were stained with methenamine silver or hema-
toxylin and eosin.
DC cultures. BALB/c BM-DCs were induced by culturing BM cells
with 10 ng/ml GM-CSF (PeproTech) and 120  /ml polymyxin B as de-
scribed previously (51). LPS, Pam3CSK4 (Calbiochem), curdlan, zymosan,
or laminarin were added at the indicated concentration on day 5 and the
expression of surface markers or the concentration of cytokines in the su-
pernatant was analyzed on day 6 using a FACSCalibur (BD Biosciences) or
ELISA (eBioscience), respectively.
Preparation of synovial cells. Synovial tissues from ankle joints were
digested with 400 Mandl U/ml of Liberase Brendzyme II (Roche) in
RPMI 1640 medium for 1 h at 37 C; digested cells were filtrated through a
nylon mesh to prepare single cell suspensions.JEM VOL. 201, March 21, 2005 959
ARTICLE
Statistics.  Mann-Whitney U test was used for statistical analyses.
Online supplemental material.  Table S1 shows the incidence of fungal
infection in non-SPF SKG mice. PCR products of fungal 18S rDNA or
ITS1 in their lung DNA were sequenced to determine the infecting fungal
species. Fig. S1 shows that 2A11 anti–Dectin-1 mAb blocked in a dose-
dependent fashion the enhancement of CD86 expression in BM-DCs by
curdlan. Fig. S2 shows the production of IL-12, assessed by ELISA, from
BM-DCs stimulated with laminarin, curdlan, zymosan, or LPS. Fig. S3
shows the influence of  -glucans on the proliferation of BALB/c CD4  T
cells stimulated by soluble anti-CD28 and plate-bound anti-CD3. Online
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20041758/DC1.
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